Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
420 questions in 57 reviews · Gut
current versionsNo studies 420 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Adalimumab vs active comparator Serious adverse events · People with quiescent Crohn's disease (ileocolic resection) Adalimumab for maintenance of remission in Crohn's disease (2020) · Cochrane | no estimate extracted | NR | No studies |
Adalimumab vs active comparator Withdrawal due to adverse events · People with quiescent Crohn's disease (ileocolic resection) Adalimumab for maintenance of remission in Crohn's disease (2020) · Cochrane | no estimate extracted | NR | No studies |
Adalimumab vs active comparator Failure to maintain clinical or endoscopic response with prior TNF‐α antagonist exposure · People with quiescent Crohn's disease (ileocolic resection) Adalimumab for maintenance of remission in Crohn's disease (2020) · Cochrane | no estimate extracted | NR | No studies |
Adalimumab vs active comparator Failure to maintain clinical remission · People with quiescent Crohn's disease (ileocolic resection) Adalimumab for maintenance of remission in Crohn's disease (2020) · Cochrane | no estimate extracted | NR | No studies |
Rifaximin vs placebo Maintenance of clinical remission · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Rifaximin vs placebo No episodes acute pouchitis · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Lactobacillus GG vs placebo Clinical remission · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Lactobacillus GG vs placebo Maintenance of clinical remission · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Lactobacillus GG vs placebo No episodes acute pouchitis · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Ciprofloxacin vs metronidazole Clinical improvement · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Lactobacillus GG vs placebo Adverse events · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Glutamine vs butyrate Clinical remission · Patients with chronic pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Glutamine vs butyrate Clinical improvement · Patients with chronic pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Glutamine vs butyrate No episodes acute pouchitis · Patients with chronic pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Glutamine vs butyrate Adverse events · Patients with chronic pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Bismuth enema vs placebo Clinical remission · Patients with chronic pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Bismuth enema vs placebo Maintenance of clinical remission · Patients with chronic pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Bismuth enema vs placebo No episodes acute pouchitis · Patients with chronic pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Ciprofloxacin vs metronidazole Maintenance of clinical remission · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
De Simone Formulation vs placebo Clinical remission · Patients with chronic pouchitis or ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
De Simone Formulation vs placebo Clinical improvement · Patients with chronic pouchitis or ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
De Simone Formulation vs no treatment Clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
De Simone Formulation vs no treatment Clinical improvement · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
De Simone Formulation vs no treatment Maintenance of clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Ciprofloxacin vs metronidazole No episodes acute pouchitis · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
De Simone Formulation vs no treatment Adverse events · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Bifidobacterium longum vs placebo Clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Bifidobacterium longum vs placebo Clinical improvement · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Bifidobacterium longum vs placebo Maintenance of clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Bifidobacterium longum vs placebo Adverse events · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Allopurinol vs placebo Clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Allopurinol vs placebo Clinical improvement · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Allopurinol vs placebo Maintenance of clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Allopurinol vs placebo Adverse events · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Tinidazole vs placebo Clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Tinidazole vs placebo Clinical improvement · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Tinidazole vs placebo Maintenance of clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Tinidazole vs placebo Adverse events · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Adalimumab vs placebo Clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Adalimumab vs placebo Maintenance of clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Adalimumab vs placebo No of episodes of acute pouchitis · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Adalimumab vs placebo Adverse events · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Clostridium probiotic vs placebo Clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Clostridium probiotic vs placebo Clinical improvement · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Clostridium probiotic vs placebo Maintenance of clinical remission · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Clostridium probiotic vs placebo Adverse events · Patients with ileal pouch‐anal anastomosis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Metronidazole vs budesonide enema Maintenance of clinical remission · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Metronidazole vs budesonide enema No episodes acute pouchitis · Patients with acute pouchitis Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis (2019) · Cochrane | no estimate extracted | NR | No studies |
5‐ASAs vs placebo Radiologic relapse · people with surgically‐induced remission in Crohn's disease Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease (2019) · Cochrane | no estimate extracted | NR | No studies |
5‐ASAs vs placebo Health related quality of life · people with surgically‐induced remission in Crohn's disease Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease (2019) · Cochrane | no estimate extracted | NR | No studies |